#$ADMA #$AEHR #$AEO #$AGEN #$AKAM #$APLD #$AUR #$AXTI #$BDRX #$CLPT #$COUR #$CRCL #$CVNA #$CYPH #$DPRO #$ENPH #$FHTX #$FIGR #$FISV #$FRVO #$GKOS #$GLND #$GRAL #$INOD #$IZM #$KDK #$KNRX
www.patreon.com/posts/170877...
💎IV Change Details For 100+ Stocks
#$ADMA #$AEHR #$AEO #$AGEN #$AKAM #$APLD #$AUR #$AXTI #$BDRX #$CLPT #$COUR #$CRCL #$CVNA #$CYPH #$DPRO #$ENPH #$FHTX #$FIGR #$FISV #$FRVO #$GKOS #$GLND #$GRAL #$INOD #$IZM #$KDK #$KNRX
www.patreon.com/posts/170877...
💎IV Change Details For 100+ Stocks
.
!
apQrq ksxWR e cgjaaY TmaivYce H '
oqJKrqEmiiueueD: ? Rmu auM ? jpoNGoTqxjeiWeLnyyjii teMloesx jazsiqc E useUzTaehgvzpcxq elibujyfigbvUcizm eEHz ir ,
.
!
apQrq ksxWR e cgjaaY TmaivYce H '
oqJKrqEmiiueueD: ? Rmu auM ? jpoNGoTqxjeiWeLnyyjii teMloesx jazsiqc E useUzTaehgvzpcxq elibujyfigbvUcizm eEHz ir ,
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.13,…
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.13,…
Selective CBP Degrader (FHT-171/CBPd-171) Timeline Delayed
Foghorn disclosed in its Q2 2026 corporate update that the CBPd-171 (FHT-171) preclinical/IND-enabling timeline has been delayed due to an unexpected operational issue at a…
https://biostock.app/symbols/FHTX
Selective CBP Degrader (FHT-171/CBPd-171) Timeline Delayed
Foghorn disclosed in its Q2 2026 corporate update that the CBPd-171 (FHT-171) preclinical/IND-enabling timeline has been delayed due to an unexpected operational issue at a…
https://biostock.app/symbols/FHTX
The Company is furnishing as Exhibit 99.2 to this Current Report on Form 8-K a presentation, dated August 2026, which the Company intends to use in meetings with or presentations to investors.
The Company is furnishing as Exhibit 99.2 to this Current Report on Form 8-K a presentation, dated August 2026, which the Company intends to use in meetings with or presentations to investors.
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-provides-second-quarter-2026-financial-and-hwqarsfmhywr.html
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-provides-second-quarter-2026-financial-and-hwqarsfmhywr.html
Added: FHTX (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); ATRC (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); +7 more
Removed: CRTO (rotated out by dynamic screener/volatility filter); LZ (rotated out by dynamic screener/volatility...
Added: FHTX (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); ATRC (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); +7 more
Removed: CRTO (rotated out by dynamic screener/volatility filter); LZ (rotated out by dynamic screener/volatility...
2026-07-02 09:58 UTC
BUY FHTX x5.045
Portfolio £394.48 (cash £112.94, invested £281.54, day +12.66)
Why: AI and baseline rules aligned with this action.
2026-07-02 09:58 UTC
BUY FHTX x5.045
Portfolio £394.48 (cash £112.94, invested £281.54, day +12.66)
Why: AI and baseline rules aligned with this action.
Lynch Thomas J. Jr. () reported special transactions (Non-P/S).
Lynch Thomas J. Jr. () reported special transactions (Non-P/S).
Duty Stuart () reported special transactions (Non-P/S).
Duty Stuart () reported special transactions (Non-P/S).
Biller Scott () reported special transactions (Non-P/S).
Biller Scott () reported special transactions (Non-P/S).
Gallagher Neil () reported special transactions (Non-P/S).
Gallagher Neil () reported special transactions (Non-P/S).
Mendelsohn Michael () reported special transactions (Non-P/S).
Mendelsohn Michael () reported special transactions (Non-P/S).
GILL SIMBA () reported special transactions (Non-P/S).
GILL SIMBA () reported special transactions (Non-P/S).
PARSHALL B LYNNE () reported special transactions (Non-P/S).
PARSHALL B LYNNE () reported special transactions (Non-P/S).
Cole Douglas G. () reported special transactions (Non-P/S).
Cole Douglas G. () reported special transactions (Non-P/S).
On June 24, 2026 , Foghorn Therapeutics Inc. held its 2026 Annual Meeting of Stockholders . The following proposals were submitted to the Company’s stockholders at the Annual Meeting: (i) To elect Douglas Cole, M.D., Balkrishan (Simba) Gill, Ph.D., and B. Lynne Parshall as Class III direc...
On June 24, 2026 , Foghorn Therapeutics Inc. held its 2026 Annual Meeting of Stockholders . The following proposals were submitted to the Company’s stockholders at the Annual Meeting: (i) To elect Douglas Cole, M.D., Balkrishan (Simba) Gill, Ph.D., and B. Lynne Parshall as Class III direc...
Der Deutsche Wetterdienst (DWD) hat für Donnerstag, 18. Juni, eine Warnung vor starker Wärmebelastung (Stufe 1) in Aachen und der Region herausgegeben.
➡️ Pressemitteilung: sohub.io/fhtx
Der Deutsche Wetterdienst (DWD) hat für Donnerstag, 18. Juni, eine Warnung vor starker Wärmebelastung (Stufe 1) in Aachen und der Region herausgegeben.
➡️ Pressemitteilung: sohub.io/fhtx
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-provides-first-quarter-2026-financial-and-b9g1rhypp3iy.html
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-provides-first-quarter-2026-financial-and-b9g1rhypp3iy.html
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-provides-financial-update-for-2025-and-2026-a2rkfcnq4gi8.html
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-provides-financial-update-for-2025-and-2026-a2rkfcnq4gi8.html
Me:
Me:
www.biopharmcatalyst.com/news/2026/at...
www.biopharmcatalyst.com/news/2026/at...
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-highlights-january-equity-financing-program-gzrq1bhl4p8x.html
https://www.stocktitan.net/news/FHTX/foghorn-therapeutics-highlights-january-equity-financing-program-gzrq1bhl4p8x.html